Has blood volume an impact on serum PSA levels?

World Journal of Urology

Volumn 28, Issue 6, 2010, Pages 693-697

  Ponholzer, Anton ^a   Temml, Christian ^a   Madersbacher, Stephan ^a  

^a Donauspital SMZ Ost ^*  (Austria)

Author keywords

Obesity; Prostate cancer; Tumour marker; Validity

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD; BLOOD VOLUME; BODY MASS; COHORT ANALYSIS; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSTATE TUMOR; RETROSPECTIVE STUDY; WAIST HIP RATIO;

ADIPOSE TISSUE; ADULT; BLOOD VOLUME; BODY MASS INDEX; COHORT STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; WAIST-HIP RATIO;

EID: 78049452139     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-009-0468-z     Document Type: Article

References (14)

1. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Copien DE, Yuan JJ, Petros JA, Andriole GL (1991) Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324: 1156-1161.
2. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E (1987) Prostate-specific antigen as a serum marker for adenocarcinoma for the prostate. N Engl J Med 317: 909-916.
3. Loeb S, Catalona WJ (2007) Prostate-specific antigen in clinical practice. Cancer Lett 249: 30-39.
4. Gonzalgo ML, Carter HB (2007) Update on PSA testing. J Natl Compr Canc Netw 5: 737-742.
5. Werny DM, Thompson T, Saraiya M, Freedman D, Kottiri BJ, German RR, Wener M (2007) Obesity is negatively associated with PSA in US men, 2001-2004. Cancer Epidemiol Biomarkers Prev 16: 70-76.
6. Fowke JH, Signorelle LB, Chang SS, Matthews CE, Buchowski MS, Cookson MS, Ukoli FM, Blot WJ (2006) Effects of obesity and height on PSA and percentage of fPSA levels among African-American and Caucasian men. Cancer 107(10): 2361-2367.
7. Baillargeon J, Pollock BH, Kristal AR, Bradshaw P, Hernandez J, Basler J, Higgins B, Lynch S, Rozansky T, Troyer D, Thompson I (2004) The association of BMI and PSA in a population-based study. Cancer 103(5): 1092-1095.
8. Freedland SJ, Platz EA, Presti JC, Aronson WJ, Amling CL, Kane CJ, Terris MK (2006) Obesity, serum PSA and prostate size: implications for prostate cancer detection. J Urol 175: 500-504.
9. Baraqawi AB, Golden BK, O'Donnell C, Brawer MK, Crawford ED (2005) Observed effect of BMI on tPSA and cPSA: analysis from a national screening program. Urology 65: 708-712.
10. Ku JH, Kim ME, Lee NK, Park YH, Ahn JO (2003) Influence of age, anthropometry and hepatic and renal function on serum PSA levels in healthy middle-aged men. Urology 61: 132-136.
11. Banez LJ, Hamilton RJ, Partin AW, Vollmer RT, Sun L, Rodriguez C, Wang Y, Terris MK, Aronson WJ, Presti JC, Kane CJ, Amling CL, Moul JW, Freedland SJ (2007) Obesity-related hemodilution and PSA concentration among men with prostate cancer. JAMA 298(19): 2275-2280.
12. Grubb RL III, Black A, Izmirlian G, Hickey TP, Pinsky PF, Mabie JE, Riley TL, Ragard LR, Prorok PC, Berg CD, Crawford ED, Church TR, Andriole GL Jr., PLCO Project Team (2009) Serum PSA hemodilution among obese men undergoing screening in the prostate, lung, colorectal and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 18: 748-751.
13. Vollmer RT, Humphrey PA (2003) Tumor volume in prostate cancer and serum PSA: analysis from a kinetic viewpoint. Am J Clin Pathol 119(1): 80-89.
14. Sprenger KBG, Huber K, Kratz W, Henze E (1987) Nomograms for the prediction of patients' plasma volume in plasma exchange therapy from height, weight and hematocrit. J Clin Apher 3: 185-190.